HighPassBio
Pre-clinicalDevelops T-cell receptor therapies for cancer treatment.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $12M
About
Develops T-cell receptor therapies for cancer treatment.
Cell & Gene Therapy
Funding History
1Total raised:$12M
Seed$12MJun 15, 2021